1st Total Artificial Heart Patient in Slovenia Discharged from UMC Ljubljana Using the Freedom® Portable Driver
SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal DefectContinue reading
1st Total Artificial Heart Patient in Slovenia Discharged from UMC Ljubljana Using the Freedom® Portable Driver
SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal DefectContinue reading
AZBio Fast Lane Award Winner and Leading Social Health Company for Women Partners With the Leader in Health Video to Expand Reach for Its Women’s Health Video Continue reading
Partnership with biotech firm magnifies student skillsContinue reading
December 14, 2011:
Joe Caspermeyer, Biodesign Institute via http://asunews.asu.edu/20111214_melanomadreamteam
TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.